Principal Investigator
Namrata Chandhok
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220185
Clinical Trial Summary
A Phase 1, Open-Label, Dose-Escalation with Expansion Study of SX-682 Alone and in Combination with Oral or Intravenous Decitabine in Subjects with Myelodysplastic Syndrome
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Leukemia/heme
Contact Information
Phone Number
305-243-2647